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Objective. To evaluate serum chlamydia antibody titers (CATs) in tubal occlusion or previous ectopic pregnancy and the associated
risk factors. Methods. The study population consisted of 55 women wih tubal damage and 55 parous women. CAT was measured
using the whole-cell inclusion immunoﬂuorescence test and cervical chlamydial DNA detected by PCR. Odds ratios were calcu-
lated to assess variables associated with C. trachomatis infection. Results. The prevalence of chlamydial antibodies and antibody
titers in women with tubal occlusion or previous ectopic pregnancy was signiﬁcantly higher (P<. 01) than in parous women.
Stepwise logistic regression analysis showed that chlamydia IgG antibodies were associated with tubal damage and with a larger
number of lifetime sexual partners. Conclusions. Chlamydia antibody titers were associated with tubal occlusion, prior ectopic
pregnancy, and with sexual behavior, suggesting that a chlamydia infection was the major contributor to the tubal damage in these
women.
Copyright © 2007 A. C. S. Machado et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Chlamydia trachomatis is the most common bacterial sex-
ually transmitted infection worldwide, especially among
young adults[1].Chlamydia infections remainoftenundiag-
nosed, as they are asymptomatic in the majority of patients.
Undiagnosed and untreated chlamydia infections can ascend
to the upper genital tract, where they colonize the endome-
trialmucosaandthefallopiantubes,leadingtopelvicinﬂam-
matory disease (PID). Chlamydial PID can cause tubal oc-
clusion and subsequent infertility, or partial occlusion with
an increased risk for ectopic pregnancy [2]. However, most
women who have tubal infertility or ectopic pregnancy have
never been diagnosed with C. trachomatis PID because their
infections have been asymptomatic or subclinical.
Risk factors frequently associated with chlamydial PID
and its sequelae are young age, sexual intercourse at an early
age, a large number of sexual partners, inconsistent condom
use, and the presence of chlamydia antibodies [3].
Seroepidemiological studies have indicated that chlamy-
dia infections account for a large proportion of asympto-
matic genital tract infections by demonstrating a strong link
between tubal pathology and the presence of chlamydia anti-
bodies [4, 5]. Thus, chlamydia IgG antibodies are associated
with the development of late sequelae and are markers for
previous exposure or endogenous reactivation of a previous
chlamydia infection. In chronically infected patients nega-
tiveforendocervicalC.trachomatis,apositiveserologicaltest
may be the only indication of chlamydia involvement [6].
In the present study, we evaluated whether prior expo-
sure to C. trachomatis, as determined by IgG chlamydia anti-
body titers, was associated with infertility due to tubal occlu-
sion and ectopic pregnancy in Brazilian women.
2. SUBJECTS AND METHODS
2.1. Studypopulation
The study was performed in subfertile and parous women
who entered a clinic specialized in human reproduction in
themunicipalityofGoiˆ ania,acitywith1093007inhabitants
inthecentralregionofBrazil.DuringtheperiodfromMarch2 Infectious Diseases in Obstetrics and Gynecology
to December 2001, 110 women aged 18 to 38 were selected.
Group I consisted of 33 women with infertility due to unilat-
eral or bilateral tubal occlusion, conﬁrmed by laparoscopy,
and 22 women that presented one or more prior episodes
of ectopic pregnancy. The group II consisted of 55 parous
women.
2.2. Datacollectionandbloodsamples
Women who had used oral or topical vaginal antimicrobial
treatments 15days prior to sample collection were excluded
from the study. After giving written consent, women under-
went standardized interviews concerning demographic char-
acteristics, gynecological and obstetrics antecedents, self be-
haviors, potential risk factors for cervical and vaginal in-
fections and symptoms. Peripheral blood was collected and
all sera were transported, under refrigerated conditions, to
the Laboratory of Cellular Immunology, Institute of Tropi-
cal Pathology and Public Health of the Federal University of
Goi´ as, where they were cryopreserved at −20◦C.
2.3. Endocervicalsamplecollection
The gynecological examination included a careful examina-
tion of the abdomen, external and internal genitalia, and
a speculum examination was performed. After cleaning the
ectocervix, collection proceeded with an appropriate swab,
which was introduced into the endocervix and then rotated
for ﬁve seconds and removed carefully. It was immediately
placed in a PCR transportation tube and agitated for ﬁve sec-
onds. The samples were transported to the laboratory, where
they were at 2–8◦C until processing, which occurred within
7days.
2.4. PCRforC.trachomatis
C. trachomatis DNA was ampliﬁed using the Amplicor kit
(Roche Molecular Systems, Branchburg, NJ, USA), accord-
ing to the manufacturer’s instructions. The internal control
was used in each ampliﬁcation reaction, such as positive and
negative controls to C. trachomatis, purchased by the kit.
2.5. Serologicalmethods
Serum samples were assayed for chlamydia IgG antibodies
employing the Hemagen Virgo C. trachomatis I g Gt e s t( E l e c -
tronucleonics Incorporation, Columbia, Ill, USA), according
to the manufacturer’s instructions. This is a whole cell inclu-
sion immunoﬂuorescence assay (WIF) that uses L2 serotype
of C. trachomatis. Positive reactions, inclusions presenting a
brilliant apple green ﬂuorescence, were identiﬁed with the
aid of a ﬂuorescence microscope (Olympus Vanox with a B2
ﬁlter) at 400× magniﬁcation. For a quantitative determina-
tion, serial dilutions in PBS were performed. Dilutions of
sera were expressed as antibody titers from 1/16 to 1/4096,
or negative (<1/16).
3. DATA ANALYSIS
Data processing and analyses were realized using the soft-
ware programs Epi-Info 6.0 (CDC, Atlanta, Ga, USA) and
SPSS 8.0 (SPSS, Chicago, Ill, USA). Initially, a descriptive
analysis of the main sociodemographic characteristics, sex-
ual behavior of the participants, and its related risk factors
was performed. The prevalence of C. trachomatis antibodies
was calculated with corresponding 95% conﬁdence interval
(CI) and compared between groups by the χ2 test or the Fis-
cher exact test. For comparison of chlamydia IgG antibody
titers, the Mann-Whitney test was used. Univariate and mul-
tivariatelogisticregressionanalyseswereperformedtodeter-
mine the risk factors associated with chlamydial antibodies.
P<. 05 were considered statistically signiﬁcant.
4. APPROVAL
The study protocol was approved by the Ethics Commit-
tee on Human and Animal Medical Research of the Uni-
versity Hospital, Federal University of Goi´ as (Protocol no.
047/2001).
5. RESULTS
The demographic characteristics and sexual history of the
studypopulationareoutlinedinTable 1.Themeanage ±the
standard deviation for group I was 30.7±4.3 years, while for
group II it was 34.0 ± 4.6 years. Among the 55 women from
groupI,thegreatmajorityweremarried/cohabiting(87.3%);
the same was observed in group II (81.8%). More than 2/3 of
the population of groups I (91.0%) and II (76.3%) were ed-
ucated to high school or university level, either complete or
incomplete, which indicates a good level of education in this
population. In relation to sexual behavior, the mean age for
initiating sexual intercourse in group I was 19.4 ± 3.7y e a r s
old and for group II, 18.4 ± 2.7 years old. Seventeen women
fromgroupI(30.9%)and11fromgroupII(20.0%)reported
having four or more partners in life.
The prevalence of chlamydia IgG antibodies was signiﬁ-
cantly higher (P<. 01) in the group I (31/55–56.4%) when
compared to group II (17/55–31.0%). In the women with
tubal occlusion this value was 54.5% and in those with previ-
ous ectopic pregnancy it was 59.1% (P>. 05). Nine women
in the group I (16.4%) reported a previous PID episode. The
clinical diagnosis for PID was based on the following crite-
ria: acute pelvic pain, especially in the postmenstrual period,
fever, abnormal cervical discharge, uterine/adnexial tender-
ness, and cervical motion tenderness. Eight of these women
(88.9%) presented with chlamydia IgG antibodies.
Among the 31 positive samples from group I, 23 (74.2%)
presented titers greater than 1/64, while in group II this
occurred in only two (11.8%) of the 17 positive samples
(P<. 01) (Figure 1). Moreover, titers equal to or greater than
1/128 were found in 42.4% of the samples of women with
tubal occlusion and in 40.9% of those with previous ectopic
pregnancy (P<. 05). Titers ≥1/1024 were found in six pa-
tients (21.4%) and two of them were positive to C. trachoma-
tis plasmid DNA.A. C. S. Machado et al. 3
Table 1: Sociodemographic characteristics and sexual behavior of
55 women with tubal occlusion or previous ectopic pregnancy
(group I) and 55 parous women (group II), from Goiˆ ania, Goi´ as,
Brazil, in 2001.
Variable Group I n (%) Group II n (%)
Maritalstatus
Married/cohabiting 48 (87.3%) 45 (81.8%)
Single 07 (12.7%) 10 (18.2%)
Schooling, y
<5— 0 2 ( 3 . 6 % )
5–8 05 (9.1%) 11 (20.0%)
9–11 25 (45.5%) 29 (52.7%)
>11 25 (45.5%) 13 (23.6%)
1st sexual intercourse,y
≤15 07 (12.7%) 11 (20.0%)
>15 48 (87.3%) 44 (80.0%)
Number of partners
1 20 (36.4%) 22 (40.0%)
2–3 18 (32.7%) 22 (40.0%)
≥4 17 (30.9%) 11 (20.0%)
PreviousSTD
Yes 04 (7.3%) 04 (7.3%)
No 51 (92.7%) 51 (92.7%)
PreviousSTDpartner∗
Yes 04 (7.3%) 02 (4.4%)
No 44 (91.7%) 43 (95.6%)
PreviousPID
Yes 09 (16.4%) —
No 46 (83.6%) 55 (100.0%)
Relations with symptomatic
partner∗
Yes 05 (10.4%) 03 (6.7%)
No 43 (89.6%) 42 (93.3%)
∗These items were only replied to by women married or in
consensual union.
C. trachomatis DNA was only detected in two endocervi-
cal samples from group I (3.6%; IC 95%) and in none of the
55 samples from group II.
Univariate analysis was performed to determine the de-
gree of association between sociodemographic ﬁndings and
sexual behavior and the presence of chlamydia antibodies
(Table 2). The odds ratios (OR), with their respective 95%
conﬁdence intervals (CI) showed statistical signiﬁcance in
group I for the variables: number of sexual partners (2 to
3p a r t n e r sc o m p a r e dt o1 ;≥4 compared to 1) and previous
PID. In group II, only the previous STD variable showed sig-
niﬁcant association.
After adjustment to a logistic regression model, chlamy-
diaIgGantibodiesweresigniﬁcantlyassociatedwithagreater
number of lifetime sexual partners (estimated OR 3.06; CI
95% 1.7–5.5; P<. 05) and with tubal pathology (estimated
OR 2.93; CI 95% 1.2–6.9; P<. 05).
Parous women
Tubal damage























Figure 1: Frequency of C. trachomatis antibody titers in women
with tubal damage and in parous women.
6. DISCUSSION
In the current study, we found a high prevalence rate and
titers of chlamydia IgG antibody among women with tubal
occlusion or previous ectopic pregnancy from the central
part of Brazil and an association between chlamydial anti-
bodies and a higher number of lifetime sexual partners.
The prevalence rate of chlamydia IgG antibodies was
signiﬁcantly higher (56.4%) in the subfertility group than
in parous women (31.0%). These results are in agreement
with other studies that used immunoﬂuorescence, like that
of Kihlstr¨ om et al. [7], who found chlamydia IgG antibodies
in 56% of women with previous PID, tubal factor infertil-
ity, or prior ectopic pregnancy. Other authors have also re-
ported high levels of chlamydia antibodies in women with
tubal pathology, using other diagnostic tests [8].
Chlamydia antibody titers (CATs) have been shown to be
of predictive value in the detection of tubal damage and in-
creased risk of ectopic pregnancy [4, 9, 10] and are quanti-
tatively related to the severity of damage [6]. These obser-
vations are in agreement with our results. Titers equal to or
greater than 1/128 were found in around 40% of the women
withtubalocclusionorpreviousectopicpregnancyandinsix
patients the titers were ≥1/1024 (21.4%).
The immunoﬂuorescence test employed in the present
study is highly sensitive, as shown by a blinded comparative
study of other serological tests for C. trachomatis antibody
carried out in two international centres [11, 12]. The test
detects both group-speciﬁc lipopolysaccharide and species-
speciﬁc antibodies [13]. Therefore, women with a positive
serology but with a normal pelvis may have cross-reactive
responses to past infection with other species of chlamydia
such as Chlamydia pneumoniae [14]o rChlamydia psittaci
[12, 15]. In our study we did not evaluate C. pneumoniae an-
tibodies. However, den Hartog et al. [6] evaluated serum of
womenwithdistaltubalpathology(DTP)andfoundthatthe
presence of C. trachomatis antibodies was the only indepen-
dent predictor for DTP. The predictive value of C. trachoma-
tis antibodies for DTP could not be improved by adding test4 Infectious Diseases in Obstetrics and Gynecology
Table 2: Univariate analysis of the characteristics associated with the presence of chlamydia IgG antibodies in women with tubal occlusion
or previous ectopic pregnancy (group I, n = 55) and in parous women (group II, n = 55), in Goiˆ ania, Goi´ as, Brazil, in 2001.
Variable Group I IgG+ OR IC 95% Group II IgG+ OR IC 95%
Age, y
≤30 18 (58.1%) 2.31 (0.7–8.0) 05 (29.4%) 2.75 (0.5–13.9)
>30 13 (41.9%) 12 (70.6%)
Maritalstatus
Married/cohabiting 06 (19.4%) 14 (82.4%)
Single 25 (80.6%) 5.52 (0.6–131.2) 03 (17.6%) 1.05 (0.2–6.1)
Schooling, y
≤8 04 (12.9%) 3.41 (0.3–86.0) 03 (17.6%) 0.60 (0.1–2.9)
>8 27 (87.1%) 14 (82.4%)
N
o of sexual partnersin life
≥4 14 (45.2%) 18.67 (2.9–150.1)∗ 06 (35.3%) 4.08 (0.7–26.3)
2 or 3 13 (41.9%) 10.40 (1.9–65.2)∗ 06 (35.3%) 1.27 (0.3–6.2)
1 04 (12.9%) 05 (29.4%)
Age at ﬁrstsexual intercourse,y
≤15 06 (19.4%) 5.52 (0.6–131.2) 04 (23.5%) 1.36 (0.3–6.6)
>15 25 (80.6%) 13 (76.5%)
PreviousSTD
Yes 03 (9.7%) 2.46 (0.2–65.9) 03 (17.6%) 7.93 (0.6–216.4)∗
No 28 (90.3%) 14 (82.4%)
PreviousSTDpartner
Yes 02 (8.0%) 0.91 (0.1–10.2) 01 (7.1%) 2.31 (0.0–93.2)
No 23 (92.0) 13 (92.6%)
PreviousPID
Yes 08 (25.8%) 8.00 (0.9–184.5)∗
No 23 (74.2%)
Relation with symptomaticpartner
Yes 03 (12.0%) 1.43 (0.2–13.9) 01 (7.1%) 1.12 (0.0–18.2)




Based on the correlation between chlamydia IgG anti-
body titers and the presence of tubal sequelae, some authors
suggest that testing for these antibodies should be part of the
basic routine investigation in infertility clinics [5, 16]. Land
et al. [10] have incorporated this procedure into the routine
oftheirservicessince1992.Thepredictivevalueofchlamydia
IgGantibody titersdetected byindirect immunoﬂuorescence
in the diagnosis of tubal pathology is considered by some to
be comparable, or even superior to, that of histerosalpingog-
raphy, according to some authors [17, 18].
An association between the presence of chlamydia IgG
antibodies and the number of sexual partners occurred in
this study. This ﬁnding is in agreement with previous studies
which show that this is one of the most relevant risk factors
in the acquisition of PID and its sequelae [19, 20].
In the current study, chlamydia IgG antibodies were also
animportantriskfactorfortubalocclusionandectopicpreg-
nancy. After adjustment to a multivariate model, a frequency
of 2.9-fold greater exposure to C. trachomatis in subfertile
womenwasfoundincomparisonwithparouswomen.These
data suggest a positive association between chlamydia infec-
tion and the risk of developing ectopic pregnancy and tubal
infertility. In a previous study, it was shown that exposure to
this pathogen is approximately three-fold greater in women
with tubal infertility and ectopic pregnancy in comparison
with a control group of fertile women [21].
Only two women in the present study were positive for
C. trachomatis in their endocervix by PCR. Other authors
have also found low prevalence rates of 1.3–8.3% in simi-
lar populations, using nucleic acid ampliﬁcation techniques
[11, 22, 23]. One possible explanation for this low chlamydia
detection rate could be that in women with tubal infertility
or with a previous ectopic pregnancy the bacterium has as-
cended through the cervix and endometrium to the fallop-
ian tubes and is no longer present in the endocervix. This
hypothesis is supported by the data of Patton et al. [24].A. C. S. Machado et al. 5
The authors found C. trachomatis DNA and/or antigens in
fallopian tubes from 19 of 24 women (79.2%) with tubal
factor infertility suggesting a persistent upper genital tract
chlamydial infection. Furthermore, evidence exists that C.
trachomatis may persist in a viable and metabolically active
state in the upper genital tract, despite negative PCR results
from the cervix. Possible reactivation of the microorganism,
for example by uterine instrumentation, may result in a re-
newed upper genital tract infection [25].
In conclusion, we demonstrated a high prevalence and
titers of chlamydia IgG antibody in Brazilian women with
tubal occlusion or prior ectopic pregnancy. Chlamydia an-
tibodies were associated with sexual behavior. Thus, an in-
apparent chlamydia infection could have triggered these se-
quelae in the studied population conﬁrming the importance
of C. trachomatis as a cause of tubal dysfunction in this
population. For practical clinical purposes, chlamydia serol-
ogy is useful mainly as a screening test for the likelihood of
tubal damage in infertile women and may facilitate decisions
on which women should proceed with further more inva-
sive investigations. Our data reinforce the need for public
health policies in developing countries, which promise triage
and eventual treatment for young women with C. trachoma-
tis genital infections, thus avoiding the serious sequelae to
women’s reproductive health and a reduction in the ﬁnancial
burden hospital commitment.
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